Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Apr 25;316(7140):1303-9.
doi: 10.1136/bmj.316.7140.1303.

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group

M Eccles  1 , N Freemantle, J Mason
Affiliations
Review

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group

M Eccles et al. BMJ. .

Erratum in

  • BMJ 1998 Jun 6;316(7146):1733
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Risk ratio of non-fatal myocardial infarction, stroke, or death from vascular causes in patients at high risk of a vascular event. Meta-analysis of 83 trials
Figure 2
Figure 2
Relative risk of non-fatal myocardial infarction, stroke, or death from vascular causes in patients at high risk of a vascular event who were taking aspirin or an alternative antiplatelet drug. Meta-analysis of 78 trials
Figure 3
Figure 3
Risk differences (%) for non-fatal myocardial infarction, stroke, or death from vascular causes in patients at high risk of a vascular event treated or not treated with an antiplatelet agent
Figure 4
Figure 4
Relative risk of non-fatal myocardial infarction, stroke, or death from vascular causes in relation to treatment with aspirin or an alternative antiplatelet agent. Meta-analysis of 32 trials
See this image and copyright information in PMC

Comment in

References

    1. North of England Evidence Based Guidelines Development Project. Evidence based guideline for the use of aspirin for the secondary prophylaxis of vascular disease in primary care. Newcastle upon Tyne: Centre for Health Services Research; 1997.
    1. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice. Fourth national study 1991-1992. London: HMSO; 1995.
    1. Eccles M, Freemantle N, Mason J. Methods of developing guidelines for efficient drug use in primary care. BMJ. 1998;316:1232–1235. - PMC - PubMed
    1. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet treatment. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106. - PMC - PubMed
    1. Juul-Möller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Ömblus R.for the Swedish Angina Pectoris Aspirin Trial Group. Double blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris Lancet 19923401421–1425. - PubMed

MeSH terms